Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, August 16, 2017
Sekisui XenoTech announced the addition of the H0606.S9(AX) Pooled Human Liver S9 and H0606.C(AX) Pooled Human Liver Cytosol test systems to the company’s catalog of in vitro drug development products.
read more
Wednesday, August 16, 2017
A market evaluation by Future Market Insights highlights the small molecule API market in a new research study.
read more
Thursday, August 17, 2017
Alamo Pharma Services has formed a specialized division of the company that offers partner organizations recruiting services.
read more
Thursday, August 17, 2017
ACF Bioservices announced the completion of construction on its dedicated cGMP-compliant 3400 square foot facility for gene and cell therapy product testing.
read more
Ligand will receive a $2 million payment from WuXi Biologics subsequent to their licensing of exclusive rights to the anti-PD-1 antibody GLS-010 to Arcus Biosciences.
read more
QPharma, a premier provider of compliance and commercial services to the life sciences industry, is expanding its footprint with the opening of a new office in the Somerset area of New Jersey.
read more
Allscripts has partnered with Elligo Health Research to assist clinicians to conduct clinical trial studies in their own clinics.
read more
Pelican BioThermal announced the opening of their first service center in Puerto Rico taking place August 24.
read more
Champions Oncology announced a strategic collaboration with AstraZeneca to develop novel cohorts of PDX models.
read more
Medidata announced an enterprise agreement with Chinese healthcare group, Shanghai Fosun Pharmaceutical.
read more
Ligand Pharmaceuticals announced the appointment of Nancy Ryan Gray, Ph.D. to the company’s Board of Directors.
read more
Evotec AG announced has successfully completed the acquisition of Aptuit as announced in detail on 30 July 2017.
read more
PAREXEL and Osaka International Cancer Institute announced that they have formed an alliance to advance clinical development in Japan.
read more
Avista Healthcare and Envigo, an early stage non-clinical contract research organization jointly announced that they have entered into a definitive merger agreement.
read more
Oxford Genetics announced a £7.5 million investment into its operations in the US and the UK by Mercia Technologies PLC, an existing investor, and Invesco Perpetual.
read more